Add like
Add dislike
Add to saved papers

Assessment of Antimicrobial Efficacy of Bioceramic Sealer, Epiphany Self-etch Sealer, and AH-Plus Sealer against Staphylococcus aureus and Candida albicans : An In vitro Study.

Aim: The aim and objective of this in vitro study was to evaluate the antimicrobial efficacy of root canal sealers (bioceramic [BC] sealer, Epiphany self-etch sealer, and AH-Plus sealer) on Staphylococcus aureus and Candida albicans .

Materials and Methods: An agar well diffusion assay method was used to determine the efficacy of the root canal sealer against S. aureus (ATCC 6538) and C. albicans (ATCC 10231). Root canal sealers were divided into three groups: BC sealer, Epiphany self-etch sealer, and AH-Plus sealer, and the standard antibiotic disc of amoxiclav and fluconazole was kept as a control against S. aureus and C. albicans . The diameters of the growth inhibition zones against S. aureus and C. albicans for each group were recorded and compared at 24 h. The differences between groups were analyzed by one-way ANOVA and Tukey's post hoc tests for intergroup analysis.

Results: AH-Plus sealer exhibited a larger zone of inhibition than the other two sealers against S. aureus and C. albicans at 24 h. The standard antibiotic disc of fluconazole, which was used as a control against C. albicans , exhibited a higher antimicrobial activity than the AH-Plus sealer at 24 h, whereas Epiphany self-etch sealer showed the least antimicrobial activity against S. aureus and C. albicans .

Conclusion: The AH-plus root canal sealer exhibits a better antibacterial action against S. aureus and C. albicans at 24 h.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app